Biotech startup EyeBio closes $65M to develop a new generation of eye disease therapies to protect, restore, and improve vision
It’s the 21st century, and there are still millions of people suffering from some forms of eye disorders. According to the Centers for Diseases and Control Prevention (CDC), approximately 12 million people 40 years and over in the United States have vision […]